ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.686,60
1,07%
S&P 500
5.206,10
0,36%
Dow Jones
39.308,35
0,65%
Euro vs US Dollar
1,07785
0,30%
Bitcoin
61.995,74
1,32%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aptevo Therapeutics Inc (APVO)

  7. Aptevo Therapeutics Inc (APVO) News

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:APVO
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
08/05/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
07/03/202414h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
05/03/202423h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
05/03/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
05/03/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
05/03/202414h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
05/03/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
06/02/202422h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
31/01/202400h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
30/01/202414h00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
16/01/202422h15Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
22/12/202322h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
12/12/202322h19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
01/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
22/11/202322h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
09/11/202323h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
03/11/202321h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
15/09/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
10/08/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202322h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202314h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202314h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
10/08/202314h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
10/08/202314h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
10/08/202314h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
03/08/202323h21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
02/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
01/08/202322h01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
18/07/202314h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APVO

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
TG
NOV
Novo Nordisk
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
TG
CBK
Commerzbank
TG
432
Arbor Metals
USOTC
RHHBY
Roche (QX)
CCOM
US100
US Tech 100
TG
TUI1
Tui
DBI
TDXP
Tec DAX
FX
EURGBP
Euro vs Sterling
COIN
SOLUSD
Solana
TG
BAYN
Bayer
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten